Nonalcoholic fatty liver disease (NAFLD) is common and partially heritable and has no
effective treatments. We carried out a genome-wide association study (GWAS) meta …

Nonalcoholic fatty liver (NAFL) and its sequelae are growing health problems. We performed
a genome-wide association study of NAFL, cirrhosis and hepatocellular carcinoma, and …

Insulin resistance (IR) is a well-established risk factor for metabolic disease. The ratio of
triglycerides to high-density lipoprotein cholesterol (TG: HDL-C) is a surrogate marker of IR …

Nonalcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease. Using
a proxy NAFLD definition of chronic elevation of alanine aminotransferase (cALT) levels …

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than 30% of
the world's adult population. While it is associated with obesity and metabolic syndrome …

Non-alcoholic fatty liver disease (NAFLD) is a complex disease linked to several chronic
diseases. We aimed at identifying genetic variants associated with NAFLD and evaluating …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) can progress to cirrhosis and
hepatic decompensation, but whether genetic variants influence the rate of progression to …

This study evaluated the effects of dietary supplementation with free-or nano-curcumin on
the growth performance, immune status and heat stress resistance of Nile tilapia …

Background Only a few of the 34 biochemical biomarkers measured in the UK Biobank
(UKB) have been associated with breast cancer, with many associations suffering from …

Summary Background & Aims Non‐alcoholic fatty liver disease (NAFLD) can develop in
individuals who are not overweight. Whether lean persons with NAFLD have lower mortality …